Skip to content

Comparing pain scores and recovery after using 2 different DPNB techniques during circumcision

Dorsal penile nerve block(DPNB) for circumcision: a comparison of ultrasound-guided vs. landmark technique. - DPNB

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-001217-16-BE
Enrollment
310
Registered
2012-05-10
Start date
2012-06-05
Completion date
Unknown
Last updated
2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain and recovery after circumcision

Interventions

Trade Name: Chirocaine Product Name: Chirocaïne Pharmaceutical Form: Solution for injection INN or Proposed INN: LEVOBUPIVACAINE CAS Number: 27262-47-1 Concentration unit: mg/ml milligram(s)/millilitr

Sponsors

UZLeuven
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: - age: 3months-12 years - undergoing circumcision - ASA 1-2 Are the trial subjects under 18? yes Number of subjects for this age range: 310 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: - intolerance or allergic reactions against products used during trial - no written informed consent of parents

Design outcomes

Primary

MeasureTime frame
Main Objective: confirming the hypothesis that the US-guided Dorsal penile nerve block will provide better and longer postoperative analgesia in circumcision patients when compared to the landmark technique.;Secondary Objective: Does the US-guided Dorsal penile nerve block reduce: time to discharge incidence of PONV analgesia need at home.;Primary end point(s): Postoperative anagesic need;Timepoint(s) of evaluation of this end point: 24 hours postoperative

Secondary

MeasureTime frame
Secondary end point(s): - duration of regional techniques - Pain scores - Hospital stay - incidence of PONV -;Timepoint(s) of evaluation of this end point: until 24 hours postoperatively

Countries

Belgium

Contacts

Public ContactAnesthesie Research

UZLeuven

christel.huygens@uzleuven.be0032016344620

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026